I et ikke- randomiseret studie blev patienter med relaps af low- grade NHL, som fik MabThera monoterapi, sammenlignet med raske, ubehandlede kontroller.
In a non-randomized study, patients with relapsed low-grade NHL who received MabThera monotherapy when compared to healthy untreated controls had a lower rate of response to vaccination with tetanus recall antigen (16% vs.